Literature DB >> 23806391

Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate?

Michael A Liss1, Kristen K Nakamura, Rachel Meuleners, Surendra B Kolla, Atreya Dash, Ellena M Peterson.   

Abstract

OBJECTIVE: To investigate the performance of screening rectal cultures obtained 2 weeks before transrectal prostate biopsy to detect fluoroquinolone-resistant organisms and again at transrectal prostate biopsy.
MATERIALS AND METHODS: After institutional review board approval for observational study, we obtained a rectal culture on patients identified for a prostate biopsy but before antibiotic prophylaxis from September 12, 2011 to April 23, 2012. The specimen was cultured onto MacConkey agar with and without 1 μg/mL ciprofloxacin. We then obtained a second rectal culture immediately before prostate biopsy after 24 hours of ciprofloxacin prophylaxis. All cultures were blinded to the practitioner until the end of the study.
RESULTS: Of 108 patients enrolled, 58 patients had both rectal cultures for comparison. The median time duration between cultures was 14 (6-119) days. There were 54 of 58 concordant pairs (93%), which included 47 negative cultures and 7 positive cultures; 2 patients (3%) who were culture negative from the first screening culture became positive at biopsy. Sensitivity, specificity, negative, positive predictive values, and area under the operator curve were 95.9%, 77.8%, 95.9%, 77.8%, and 0.868, respectively. When Pseudomonas spp. are removed from the analysis, the area under the curve is increased to 0.927.
CONCLUSION: Screening rectal cultures 2 weeks before prostate biopsy has favorable test performance, suggesting screening cultures give an accurate estimate of fluoroquinolone-resistant colonization.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23806391      PMCID: PMC3952011          DOI: 10.1016/j.urology.2013.02.068

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  23 in total

Review 1.  The kappa statistic in reliability studies: use, interpretation, and sample size requirements.

Authors:  Julius Sim; Chris C Wright
Journal:  Phys Ther       Date:  2005-03

2.  ROC analysis.

Authors:  Nancy A Obuchowski
Journal:  AJR Am J Roentgenol       Date:  2005-02       Impact factor: 3.959

3.  Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis.

Authors:  Juan P Horcajada; Jordi Vila; Antonio Moreno-Martínez; Joaquim Ruiz; Jose Antonio Martínez; Miquel Sánchez; Eladio Soriano; Josep Mensa
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

Review 4.  Extravascular penetration of ciprofloxacin. A review.

Authors:  T Bergan
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Mar-Apr       Impact factor: 2.803

5.  Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.

Authors:  Florian M E Wagenlehner; Edgar van Oostrum; Peter Tenke; Zafer Tandogdu; Mete Çek; Magnus Grabe; Björn Wullt; Robert Pickard; Kurt G Naber; Adrian Pilatz; Wolfgang Weidner; Truls E Bjerklund-Johansen
Journal:  Eur Urol       Date:  2012-06-12       Impact factor: 20.096

6.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

7.  Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study.

Authors:  M Aron; T P Rajeev; N P Gupta
Journal:  BJU Int       Date:  2000-04       Impact factor: 5.588

8.  The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?

Authors:  Joseph Feliciano; Ervin Teper; Michael Ferrandino; Richard J Macchia; William Blank; Ivan Grunberger; Ivan Colon
Journal:  J Urol       Date:  2008-01-22       Impact factor: 7.450

Review 9.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

10.  Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility.

Authors:  Joel N Maslow; Betsy Lee; Ebbing Lautenbach
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  3 in total

1.  [Antibiotic prophylaxis for transrectal prostate biopsy].

Authors:  L Schneidewind
Journal:  Urologe A       Date:  2017-01       Impact factor: 0.639

2.  Infectious complications of prostate biopsy: winning battles but not war.

Authors:  Okan Derin; Limírio Fonseca; Rafael Sanchez-Salas; Matthew J Roberts
Journal:  World J Urol       Date:  2020-02-24       Impact factor: 4.226

Review 3.  Prevalence, Risk Factors, and Clinical Relevance of Fluoroquinolone-Resistant Organisms in Rectal Cultures: Should We Target Antibiotic Prophylaxis Prior to Prostate Biopsy?

Authors:  J Van Besien; P Uvin; A M Van den Abeele; L Merckx
Journal:  Adv Urol       Date:  2016-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.